Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy.
Pediatr Blood Cancer
; 61(10): 1874-6, 2014 Oct.
Article
en En
| MEDLINE
| ID: mdl-24888336
Histiocytic sarcoma (HS) is a malignant tumor composed of proliferating cells of histiocytic origin. True HS is exceedingly rare, particularly in pediatric patients. These tumors are frequently aggressive, and outcome for patients with HS has traditionally been poor. There is currently no consensus on the optimal management of these tumors, with the literature consisting largely of case reports and small case series utilizing a wide variety of therapies. We describe a case of HS in an 8-year-old female who was successfully treated with an abbreviated leukemia chemotherapy regimen.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Protocolos de Quimioterapia Combinada Antineoplásica
/
Sarcoma Histiocítico
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Límite:
Child
/
Female
/
Humans
Idioma:
En
Revista:
Pediatr Blood Cancer
Asunto de la revista:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Año:
2014
Tipo del documento:
Article
Pais de publicación:
Estados Unidos